Rate My Professor Beata Bajorek

Professor Beata Bajorek is a Clinical Academic Pharmacist in the School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing at the University of Newcastle. She holds a Bachelor of Pharmacy, Diploma in Hospital Pharmacy, Doctor of Philosophy, and Graduate Certificate in Education Studies (Higher Education) from the University of Sydney. Following her PhD, she completed a Postdoctoral Fellowship at the Clinical Practice Advancement Center, University Health-System Consortium, Chicago, Illinois, USA. With over 25 years of experience as a hospital and community pharmacist since 1995, she has held conjoint clinical academic appointments across the Northern Sydney Local Health District at Royal North Shore Hospital, University of Sydney Faculties of Pharmacy and Nursing (over 10 years), University of New South Wales Faculty of Medicine and Health, University of Technology Sydney Graduate School of Health (10 years), University of New England Discipline of Pharmacy, and University of Queensland School of Pharmacy. Currently, she serves at the University of Newcastle, Hunter Medical Research Institute as a member of the Heart and Stroke Program, and Hunter New England Local Health District.

Professor Bajorek's research focuses on quality use of medicines, optimising pharmacotherapy, medication safety and risk assessment in high-risk patients, advanced pharmacy practice including full-scope practice, pharmacy-led interventions, clinical pharmacology and therapeutics, cardiovascular and stroke care, and clinical intervention studies. Fields of research include clinical pharmacology and therapeutics (30%), cardiovascular medicine and haematology nec (40%), and clinical pharmacy and pharmacy practice (30%). She has supervised over 25 higher degree research candidates, mentored health practitioners and researchers, served over 15 years on Human Research Ethics Committees including as Chair, developed and delivered courses in pharmacotherapy, clinical practice and research methods, and contributed to Heart Foundation and National Stroke Foundation clinical guidelines. Key publications include 'Overcoming barriers to adherence through innovative injectable medications: A systematic review of therapeutic options for cardiovascular disease, reported adherence, and perspectives on their use' (2026, British Journal of Clinical Pharmacology); 'Ensuring the quality use of medicines in clinical trials: A review and perspective on optimising the role of pharmacists' (2026, Research in Social and Administrative Pharmacy); 'Exploring the potential economic benefit of modafinil for post-stroke fatigue: A cost-effectiveness evaluation in the Australian context' (2021, International Journal of Stroke); and 'Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: A pharmacist-led multidisciplinary intervention' (2005, Journal of the American Geriatrics Society). She is an investigator on the grant 'Reducing debilitating fatigue after stroke to improve Quality of Life' (2020–2026, $1,055,675, Department of Health and Aged Care).